Adiponectin Levels after Treatment With Liraglutide (Victoza®) in Patients With Type 2 Diabetes

被引：0
|
作者：
Daskalova, Ivona
Totomirova, Tzvetelina
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2591-PO
引用
收藏
页码：A659 / A659
页数：1
相关论文
共 50 条
  • [31] Liraglutide for the Treatment of Type 2 Diabetes: A Clinical Update
    Peters, Kyle R.
    AMERICAN JOURNAL OF THERAPEUTICS, 2013, 20 (02) : 178 - 188
  • [32] Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after bariatric surgery The GRAVITAS trial
    Jecht, Michael
    DIABETOLOGE, 2019, 15 (08): : 740 - 743
  • [33] Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes
    Wu, Hao
    Lu, Zongshi
    Chen, Runyao
    Cai, Quanfang
    Wang, Miaomiao
    Zhang, Liting
    Zhu, Zhiming
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [34] Improved diastolic function in type 2 diabetes after a six month liraglutide treatment
    Saponaro, Fabio
    Sonaglioni, Andrea
    Rossi, Antonio
    Montefusco, Laura
    Lombardo, Michele
    Adda, Guido
    Arosio, Maura
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 118 : 21 - 28
  • [35] ROOTS: A multicenter study in Belgium to evaluate the effectiveness and safety of liraglutide (Victoza (R)) in type 2 diabetic patients
    Buysschaert, Martin
    D'Hooge, Dirk
    Preumont, Vanessa
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2015, 9 (03) : 139 - 142
  • [36] Basal and stimulated calcitonin levels in patients with type 2 diabetes did not change during 1 year of Liraglutide treatment
    Lunati, Maria Elena
    Grancini, Valeria
    Colombo, Carla
    Palmieri, Eva
    Resi, Veronica
    Perrino, Michela
    Orsi, Emanuela
    Fugazzola, Laura
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (01): : 1 - 6
  • [37] Repaglinide treatment does not suppress adiponectin levels despite elevated insulin secretion in Type 2 diabetes patients
    Rudovich, NN
    Spranger, J
    Möhlig, M
    Rochlitz, HJ
    Florow, D
    Dieken, MGL
    Pfeiffer, AFH
    DIABETOLOGIA, 2004, 47 : A252 - A253
  • [38] Liraglutide Improves NAFLD in Patients with Type 2 Diabetes
    Basu, Debasis
    Chaudhuri, Soumyabrata Roy
    Deka, Nilakshi
    DIABETES, 2020, 69
  • [39] Independent relationship between decrease of liver triglyceride content and increase of plasma adiponectin levels after pioglitazone treatment in patients with type 2 diabetes
    Nagasawa, K.
    Kaneko, Y.
    Taneichi, H.
    Masaya, M.
    Takahashi, T.
    Kakino, S.
    Honma, H.
    Yamashina, M.
    Ishii, M.
    Fujiwara, F.
    Kajiwara, T.
    Takebe, N.
    Takahashi, K.
    Satoh, J.
    DIABETOLOGIA, 2009, 52 : S261 - S261
  • [40] Serum adiponectin levels in Type 2 diabetes mellitus patients on maintenance hemodialysis in India
    Anandh, U.
    Kapoor, D.
    Jayashree, R.
    CLINICAL NEPHROLOGY, 2010, 74 : S155 - S155
12345